Drugs@FDA document
DUPIXENT Letter · BLA 761055 SUPPL-27
Drugs@FDA document · REGENERON PHARMACEUTICALS · Dec 27, 2021
Key facts
| Drug name | DUPIXENT |
|---|---|
| Document type | Letter |
| Application | BLA761055 |
| Submission | SUPPL-27 |
| Company | REGENERON PHARMACEUTICALS |
| Document date | Dec 27, 2021 |
At a glance
- Labeling-Package Insert, Labeling-Patient Package Insert Document categories
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: